🔎 Trials Near Me

Dachaigh › Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail › Texas

Sgrùdaidhean clionaigeach Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail ann an Texas

Tha 11 sgrùdaidhean airson Neuropathaidhean mothachaidh agus fèin-riaghailteach oighreachail a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Study of ACR-2316 in Specific Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06667141

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Houston Methodist Hospital, Houston
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07175038

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07749586

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Texas Oncology - Central/South Texas, Austin
  • Mary Crowley Cancer Research, Dallas
  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
  • agus 2 a bharrachd
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
  • University of Texas Southwestern, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
  • agus 1 a bharrachd
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

  • Texas Oncology - Central/South, Austin
  • START San Antonio, San Antonio
  • Texas Oncology - San Aantonio, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07558733

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • START, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06993844

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

  • Texas Oncology - Flower Mound, Flower Mound
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Gibl 2026 · NCT05683418

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

  • El Paso Texas Oncology, El Paso
  • Texas Oncology San Antonio, San Antonio
A’ fastadhSgrùdadh amharc
Aoisean 1 gu 100 · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05868629

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

  • Research Site, Houston
A’ fastadhÌre 1
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT07064122

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

  • Texas Oncology - West Texas, El Paso
  • Texas Oncology - Gulf Coast, The Woodlands
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Dùbh 2025 · NCT06463028

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.